Trial Outcomes & Findings for Participatory Research for Suicide Prevention in Autism (NCT NCT06552871)

NCT ID: NCT06552871

Last Updated: 2026-01-26

Results Overview

Self-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Knowledge \& Capacity scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This scale inquires about how true eight statements are for the respondent currently on a 5-point scale (Definitely not true - Definitely true). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater knowledge and capacity for suicide prevention.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

51 participants

Primary outcome timeframe

Pre-intervention, post-intervention (approximately 2 months after baseline), and 3-months after intervention

Results posted on

2026-01-26

Participant Flow

Participant milestones

Participant milestones
Measure
FLAPS
Assigned to the FLAPS intervention
Overall Study
STARTED
51
Overall Study
COMPLETED
49
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
FLAPS
Assigned to the FLAPS intervention
Overall Study
Withdrawal by Subject
2

Baseline Characteristics

Participatory Research for Suicide Prevention in Autism

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
FLAPS
n=51 Participants
Assigned to the FLAPS intervention
Age, Customized
Age · 18-29 years
8 Participants
n=25 Participants
Age, Customized
Age · 30-39 years
17 Participants
n=25 Participants
Age, Customized
Age · 40-49 years
14 Participants
n=25 Participants
Age, Customized
Age · 50-59 years
8 Participants
n=25 Participants
Age, Customized
Age · 60+ years
4 Participants
n=25 Participants
Sex/Gender, Customized
Sex · Male
8 Participants
n=25 Participants
Sex/Gender, Customized
Sex · Female
40 Participants
n=25 Participants
Sex/Gender, Customized
Sex · Other/Choose not to respond
3 Participants
n=25 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=25 Participants
Race (NIH/OMB)
Asian
0 Participants
n=25 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=25 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=25 Participants
Race (NIH/OMB)
White
45 Participants
n=25 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=25 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
35 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=25 Participants
Organization (anonymized)
AA
1 Participants
n=25 Participants
Organization (anonymized)
AB
2 Participants
n=25 Participants
Organization (anonymized)
AC
9 Participants
n=25 Participants
Organization (anonymized)
AD
6 Participants
n=25 Participants
Organization (anonymized)
AE
4 Participants
n=25 Participants
Organization (anonymized)
BA
5 Participants
n=25 Participants
Organization (anonymized)
BB
1 Participants
n=25 Participants
Organization (anonymized)
BC
2 Participants
n=25 Participants
Organization (anonymized)
BD
1 Participants
n=25 Participants
Organization (anonymized)
CA
15 Participants
n=25 Participants
Organization (anonymized)
CB
5 Participants
n=25 Participants

PRIMARY outcome

Timeframe: Pre-intervention, post-intervention (approximately 2 months after baseline), and 3-months after intervention

Population: When reporting means here, we report only those who completed the measures at each time point. For the multi-level statistical analyses, we applied baseline-observation-carried-forward to have a complete analysis including all participants.

Self-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Knowledge \& Capacity scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This scale inquires about how true eight statements are for the respondent currently on a 5-point scale (Definitely not true - Definitely true). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater knowledge and capacity for suicide prevention.

Outcome measures

Outcome measures
Measure
FLAPS
n=51 Participants
Assigned to the FLAPS intervention
Steps Toward Prevention - Autism Community Suicide Prevention: Knowledge & Capacity
Pre-study data: Knowledge & Capacity
3.98 Scores on a 5-point scale
Standard Deviation 0.53
Steps Toward Prevention - Autism Community Suicide Prevention: Knowledge & Capacity
Post-study data: Knowledge & Capacity
4.54 Scores on a 5-point scale
Standard Deviation 0.54
Steps Toward Prevention - Autism Community Suicide Prevention: Knowledge & Capacity
Follow-up data: Knowledge & Capacity
4.52 Scores on a 5-point scale
Standard Deviation 0.56

PRIMARY outcome

Timeframe: Pre-intervention, post-intervention (approximately 2 months after baseline), and 3-months after intervention

Population: When reporting means here, we report only those who completed the measures at each time point. For the multi-level statistical analyses, we applied baseline-observation-carried-forward to have a complete analysis including all participants. Baseline data for actions is only available for N=50 because one participant did not complete this section of the baseline questionnaire prior to study start.

Self-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Actions scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This inquires about how often the respondent has done twelve types of actions in the past month on a 5-point scale (Never - More than once a week). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater engagement in actions for suicide prevention.

Outcome measures

Outcome measures
Measure
FLAPS
n=50 Participants
Assigned to the FLAPS intervention
Steps Toward Prevention - Autism Community Suicide Prevention: Actions
Pre-study data: Actions
2.95 Scores on a 5-point scale
Standard Deviation 0.93
Steps Toward Prevention - Autism Community Suicide Prevention: Actions
Post-study data: Actions
3.55 Scores on a 5-point scale
Standard Deviation 0.83
Steps Toward Prevention - Autism Community Suicide Prevention: Actions
Follow-up data: Actions
3.53 Scores on a 5-point scale
Standard Deviation 0.79

SECONDARY outcome

Timeframe: Post intervention (approximately 2 months after baseline)

Population: Interviews were optional, not all participants chose to complete one.

Open-ended interview questions to understand additional outcomes that participants experienced that they attribute to the intervention.

Outcome measures

Outcome measures
Measure
FLAPS
n=18 Participants
Assigned to the FLAPS intervention
Qualitative Interview
Motivation in organization to take steps to reduce suicidality in the autistic population they serve · No evidence for this theme identified
0 Participants
Qualitative Interview
Enhanced understanding about suicide among autistic people · Evidence for this theme in interview
17 Participants
Qualitative Interview
Enhanced understanding about autism and working with autistic people · Evidence for this theme in interview
9 Participants
Qualitative Interview
Enhanced understanding about autism and working with autistic people · No evidence for this theme identified
9 Participants
Qualitative Interview
Enhanced understanding about suicide among autistic people · No evidence for this theme identified
1 Participants
Qualitative Interview
Motivation in organization to take steps to reduce suicidality in the autistic population they serve · Evidence for this theme in interview
18 Participants

Adverse Events

No Monitoring

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Anne Kirby, Principal Investigator

University of Utah

Phone: 8015814248

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place